KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Dynavax Technologies (DVAX) Equity Ratio: 2009-2025

Historic Equity Ratio for Dynavax Technologies (DVAX) over the last 17 years, with Sep 2025 value amounting to 0.56.

  • Dynavax Technologies' Equity Ratio fell 12.05% to 0.56 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.56, marking a year-over-year decrease of 12.05%. This contributed to the annual value of 0.61 for FY2024, which is 3.01% down from last year.
  • Latest data reveals that Dynavax Technologies reported Equity Ratio of 0.56 as of Q3 2025, which was up 4.89% from 0.54 recorded in Q2 2025.
  • Over the past 5 years, Dynavax Technologies' Equity Ratio peaked at 0.64 during Q3 2024, and registered a low of 0.07 during Q3 2021.
  • Its 3-year average for Equity Ratio is 0.60, with a median of 0.62 in 2023.
  • Its Equity Ratio has fluctuated over the past 5 years, first slumped by 62.52% in 2021, then spiked by 581.74% in 2022.
  • Over the past 5 years, Dynavax Technologies' Equity Ratio (Quarterly) stood at 0.21 in 2021, then soared by 175.43% to 0.59 in 2022, then rose by 5.86% to 0.62 in 2023, then fell by 3.01% to 0.61 in 2024, then dropped by 12.05% to 0.56 in 2025.
  • Its Equity Ratio was 0.56 in Q3 2025, compared to 0.54 in Q2 2025 and 0.56 in Q1 2025.